02.26.25 -- STREAM Edition: FDA Projects And Guidance For Clinical Trials

Understanding what some of the common questions the FDA gets about AI may help you as you plan to interact with the agency.

Experts in regulatory strategy, operations, and program leadership provide strategies for initiation triggers, team coordination, submission processes, and Electronic Submission Gateway (ESG).

Industry leaders dive into the FDA’s Diversity Action Plans and practical strategies for integrating diversity action plans into clinical trial operations in a presentation centered around enhancing trial diversity.

Learn about the new capabilities Medable offers to upgrade your planning, build assessment libraries, and more

As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

Learn how the FDA's Project FrontRunner expedites cancer drug approval for early advanced metastatic cancer, emphasizing efficacy and safety in earlier clinical settings.

Follow along as this panel of experts shares key insights from their experiences, highlighting the technologies and processes that lead to successful partnerships in patient-centric digital trials.

Explore innovative strategies for reducing Scope 3 emissions in clinical trials. Discover sustainable solutions that uphold quality and outcomes, crucial for achieving net-zero goals in healthcare research.

Watch as industry experts discuss real-world challenges that participants face over the course of a clinical trial and the potential improvements that could make or break a patient's experience.

Glean insight into how sponsors are amplifying patient access and involvement, while simultaneously mitigating clinician exhaustion.